PMC · DOI:10.1007/s00066-026-02511-6·February 17, 2026
DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers
Sören Schnellhardt, Simon Böke, Silke Tribius, Mechthild Krause, Marlen Haderlein, Alexander Rühle, Christoph Süß, Annett Linge, Markus Hecht, Panagiotis Balermpas
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHead and Neck Cancer Studies · Esophageal Cancer Research and Treatment · Radiopharmaceutical Chemistry and Applications